GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TiumBio Co Ltd (XKRX:321550) » Definitions » Sale Of Investment

TiumBio Co (XKRX:321550) Sale Of Investment : ₩13,616 Mil (TTM As of Mar. 2025)


View and export this data going back to 2019. Start your Free Trial

What is TiumBio Co Sale Of Investment?

TiumBio Co's sale of investment for the three months ended in Mar. 2025 was ₩0 Mil. It means TiumBio Co gained ₩0 Mil from selling investments. TiumBio Co's sale of investment for the trailing twelve months (TTM) ended in Mar. 2025 was ₩13,616 Mil.

Compared with last quarter (₩2,599 Mil in Dec. 2024 ), TiumBio Co gained less money from selling investments in Mar. 2025 (₩0 Mil).


TiumBio Co Sale Of Investment Historical Data

The historical data trend for TiumBio Co's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TiumBio Co Sale Of Investment Chart

TiumBio Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Sale Of Investment
Get a 7-Day Free Trial 110,113.68 80,556.60 150,564.23 50,543.01 13,616.20

TiumBio Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6,000.00 2,695.84 2,320.98 2,599.38 -

TiumBio Co Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩13,616 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


TiumBio Co Sale Of Investment Related Terms

Thank you for viewing the detailed overview of TiumBio Co's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


TiumBio Co Business Description

Traded in Other Exchanges
N/A
Address
49, Daewangpangyo-ro 644beon-gil, Bundang-gu, 4th floor, Gyeonggi, Seongnam, KOR, 13493
TiumBio Co Ltd is a Biopharmaceutical company. It is engaged in research and development of rare and intractable diseases. The company's products are in pipeline. It offers products such as Idiopathic pulmonary fibrosis therapies, immune chemotherapy, endometriosis therapies, hemophilia.

TiumBio Co Headlines

No Headlines